GW Pharmaceuticals (GWPH) Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019

– Epidiolex U.S. Q2 net sales of $68.4 million – – Positive…

$GWPH To Present At Investor Conferences

GW Pharmaceuticals to Present at Two Upcoming Investor Conferences LONDON, Sept. 10,…